Estimation of efficacy of Reduced form of Coenzyme Q10 (Ubiquinol) to fatigue
Not Applicable
- Conditions
- one
- Registration Number
- JPRN-UMIN000021221
- Lead Sponsor
- Center for Health Science Innovation, Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
1.Under medication. 2.Take coenzyme Q10 supplement. 3.Take medicine that might impact the outcome measures. 4.Patient of serious disease such as diabetes, live disease, renal disease, heart disease, mental disease, disease to become the motive of fatigue, cardiovascular, nerve, allergy, insomnia. 5.Pregnant and women who wish to pregnant in this study period. 6.alcholism 7.Doctor did not allow to entry to this study. 8.Entry another clinical study which ongoing or performed within 1 month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Autonomic nervous system, Oxidation stress, Antioxidant activity, Cognitive function, Condition of sleep, VAS(fatigue), These items will be determined at 0, 4, 8 and 12 weeks.
- Secondary Outcome Measures
Name Time Method Physical active mass